All News

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

Advise restriction of the nutrient, along with intensive BP control, regimens promoting adherence, use of chlorthalidone in CKD.

Scientists found that inhibiting certain immune system receptors could treat colon cancer and other diseases of the gastrointestinal tract.

The Oncomine Dx Target Test is a next-generation sequencing–based companion diagnostic developed to analyze 23 genes associated with non–small cell lung cancer in patients who harbor an activating HER2 mutation.

Pharmacy managers manage the implementation of services, including ones commensurate with everyday practice as well as newer, more patient-centered services.

A new study found that reduced tobacco use lowered deaths, person-years of lost life, and lost earnings across many states nationwide.

On the first episode, Jeremy Sasser and Jessica Langley-Loep, from the National Healthcareer Association, discuss pharmacy technician's perceptions of patients who may have opioid use disorder.

Zoledronic acid (Zometa) is indicated for the treatment of hypercalcemia that may occur with cancer.

Go-Out is a natural supplement that treats high uric acid levels.

Researchers discovered that a common anti-inflammatory drug could lower the number of patients on ventilators from COVID-19, increasing the likelihood of survival by more than 50%.

High rates of HIV can decrease with community-based support.

Both ibrutinib (Imbruvica) and venetoclax (Venclexta) carry an approved indication for use in chronic lymphocytic leukemia but do not often lead to complete remission, and therapy routinely continues indefinitely or until disease progression.

Pharmacies can play a key role in supporting patients with opioid use disorder and helping diminish stigma for patients treated with methadone, who are told by some they are still addicts despite trying to receive help.

With costs for blood and blood products continuing to rise, appropriate blood use by hospitals is more important than ever.

A new study warns that fluoroquinolone could increase the risk of altered mental status and hospitalizations for advanced chronic kidney disease patients, though it is rare.

Insurer and pharmacy benefit manager policies used to cut the cost of drugs could be so time consuming that they could put newly diagnosed atrial fibrillation patients at risk of stroke.

A potential public health benefit of 13-valent pneumococcal conjugate vaccine is the reduction of acute chest syndrome among children with sickle-cell disease.

Investigators aimed to determine how individuals with and without concomitant NSP differ in characteristics and in their perception of treatment responses to analgesics.

The Preventing Addiction Related Suicide module was found to better improve suicide knowledge, increase help-seeking behaviors, and reduce maladaptive attitudes compared with usual care for patients with substance use disorders.

Guidelines provide information on the management and treatment of this common skin condition.

Specialty pharmacies are well positioned to address disparities that affect outcomes.

Febuxostat) Uloric is a xanthine oxidase inhibitor indicated for the chronic management of hyperuricemia in patients with gout.

ClearoGout aids in the prevention of gout attacks.

University of Missouri analyzes social, structural determinants of health that worsen health disparities.

Women at high risk for breast and ovarian cancer felt less worried and better informed with educational intervention, even if their attendance of genetic counseling did not significantly increase.

Patients with gout have a 4 times greater risk of a cardiovascular episode within the 60 days following their flare up.

High school seniors who played contact sports appeared to be the most likely to abuse prescription stimulants during school, and up to 10 years after graduating.

Although some physicians caution against menopausal hormone therapy, a new study finds that it does not lead to breast cancer recurrence or mortality.